r/semaglutide Ozempic® (semaglutide) GLP-1 RA for Type 2 Diabetes Semaglutide

As such, therapy in low-risk individuals should be guided by treatment effects on metabolic outcomes, such as HbA 1c reduction and weight loss, rather than cardiovascular outcomes

Notably, activated microglia make substantial contributions to this process

Additionally, semaglutide lowered cardiovascular risk in patients with diabetes

A baseline health assessment before resistance training after GLP-1 use should include a complete metabolic panel and lipid bloodwork, fasting glucose and HbA1c levels, blood pressure measurement, and a body composition assessment, ideally via DEXA scan

Weston C, Lu J, Li N et al (2015) Modulation of glucagon receptor pharmacology by receptor activity-modifying protein-2 (RAMP2)